Empire Genomics
 | This article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Empire Genomics is a cancer molecular diagnostics company. They make genetic tests for over 200 different types of health concerns.[1] It is based in Buffalo, New York in the United States.
Dr. Norma J. Nowak founded Empire Genomics in 2006 in Buffalo, New York.[2] It developed out of a project at Roswell Park Comprehensive Cancer Center.[3] Their headquarters is located in Buffalo at the Buffalo Niagara Medical Campus.[2]
The company develops non-invasive tests that focus around health concerns such as cancer, autism and Down syndrome.[3] In 2012, Empire Genomics released a test for multiple myeloma and opened a new laboratory to focus on the test. As of 2012, Anthony Johnson is chief executive officer.[2] That same year, the company received a $400,000 grant from the Empire State Development Corporation.[3]
On February 19, 2019, the company announced the appointments of Andy Watson as CEO and Anthony Scarpello to CCO, and the opening of its new headquarters in Williamsville, NY.
References[]
- ^ Bertola, Davis. "Empire Genomics building a new $1.2M lab". Buffalo Business First. Retrieved 27 December 2012.
- ^ a b c "Empire Genomics Creating 50 Jobs on Medical Campus". City. Buffalo Rising. Archived from the original on 18 January 2013. Retrieved 27 December 2012.
- ^ a b c Watson, Stephen. "Empire Genomics plans to expand". Business. The Buffalo News. Retrieved 27 December 2012.
External links[]
- Companies based in Buffalo, New York
- Companies established in 2006
- Biotechnology companies of the United States